Titan Biotech LimitedBSE: TITANBIO

Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter & Half Year Ended September 2025.

· Issued by Titan Biotech Limited via BSE India

Filed with BSE ·

On 6ix: 6ix.com/news/board-meeting-intimation-for-consideration-and-approval-of-standalone-and-consolidated-financial-results-for-the-quarter-and-half-year-ended-september-2025

Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve the unaudited standalone & consolidated financial results for the second quarter & half year ended September 30, 2025

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Titan Biotech Limited on 6ix

Story so far

Earlier from Titan Biotech

Later from Titan Biotech

All Titan Biotech news releases